Determination of antigen binding specificities of Cryptococcus neoformans factor sera by enzyme-linked immunosorbent assay.
about
Cryptococcus neoformans chemotyping by quantitative analysis of 1H nuclear magnetic resonance spectra of glucuronoxylomannans with a computer-simulated artificial neural networkIn vitro and in vivo stability of a Cryptococcus neoformans [corrected] glucuronoxylomannan epitope that elicits protective antibodies.Monoclonal antibodies specific for immunorecessive epitopes of glucuronoxylomannan, the major capsular polysaccharide of Cryptococcus neoformans, reduce serotype bias in an immunoassay for cryptococcal antigenVariation in the structure of glucuronoxylomannan in isolates from patients with recurrent cryptococcal meningitis.Proteins in the cell wall and membrane of Cryptococcus neoformans stimulate lymphocytes from both adults and fetal cord blood to proliferateStructure and biological activities of acapsular Cryptococcus neoformans 602 complemented with the CAP64 geneExtracellular proteins of Cryptococcus neoformans and host antibody responseReactivity patterns and epitope specificities of anti-Cryptococcus neoformans monoclonal antibodies by enzyme-linked immunosorbent assay and dot enzyme assay.Monoclonal antibodies reactive with immunorecessive epitopes of glucuronoxylomannan, the major capsular polysaccharide of Cryptococcus neoformansPhenotypic heterogeneity in expression of epitopes in the Cryptococcus neoformans capsuleAntigenic and biological characteristics of mutant strains of Cryptococcus neoformans lacking capsular O acetylation or xylosyl side chains.Involvement of the capsular GalXM-induced IL-17 cytokine in the control of Cryptococcus neoformans infectionDectin-3 Recognizes Glucuronoxylomannan of Serotype AD and Serotype B to Initiate Host Defense Against Cryptococcosis
P2860
Q33991281-7D9B2BEF-DF92-4276-82A5-3450429DF1BCQ34001243-C0E83D97-B1A8-413E-ABD8-AA152E89F335Q35138768-F26859D0-B197-441D-AB10-E4DB1112A580Q35411136-F69B2BAB-8910-4FEB-9206-BDECA26FF2F3Q35530029-9EE2BEDD-526E-40E1-9FA2-9E2BD50ABF3FQ35546019-C8FADDC8-593C-410A-9AFD-BB146BE2E958Q35550533-592370BB-B762-449A-BABC-C3BCDD1BB278Q35567548-089D0C0F-6CBC-48B1-AD00-4A3CF18BBEC0Q35923662-FBD861D5-3DA8-455E-BB2A-B39EEDD862E5Q37459771-E8B5D669-634D-4E27-8A5B-A5005D7E89A4Q39746326-3F5FD4FB-82EB-4A17-8C39-DDF93DEE055EQ58608737-5047FA68-ADF1-40F2-99D0-8E8C3F3A194FQ58798947-02FFE9B8-5709-49EE-B0B0-A53E0C984D18
P2860
Determination of antigen binding specificities of Cryptococcus neoformans factor sera by enzyme-linked immunosorbent assay.
description
1995 nî lūn-bûn
@nan
1995 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Determination of antigen bindi ...... me-linked immunosorbent assay.
@ast
Determination of antigen bindi ...... me-linked immunosorbent assay.
@en
type
label
Determination of antigen bindi ...... me-linked immunosorbent assay.
@ast
Determination of antigen bindi ...... me-linked immunosorbent assay.
@en
prefLabel
Determination of antigen bindi ...... me-linked immunosorbent assay.
@ast
Determination of antigen bindi ...... me-linked immunosorbent assay.
@en
P2860
P1476
Determination of antigen bindi ...... yme-linked immunosorbent assay
@en
P2093
P2860
P304
P407
P577
1995-05-01T00:00:00Z